Menu
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.
LOS ANGELES, CA / ACCESSWIRE / September 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, publicizes that it’s investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading […] The post INVESTIGATION ALERT: The Schall Law Firm Declares it’s Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm appeared first on TodaysStocks.com .
LOS ANGELES, Sept. 18, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) investors concerning the Company''s possible…
LOS ANGELES, CA / ACCESSWIRE / September 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, proclaims that it’s investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […] The post SHAREHOLDER ACTION ALERT: The Schall Law Firm Pronounces it’s Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm appeared first on TodaysStocks.com .
Law Offices of Howard G. Smith continues its investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) investors concerning the Company’s possible violations of federal securities laws. On September 12, 2023, before the market opened, Orthofix disclosed that its Board’s independent directors made the unanimous decision to terminate for cause Keith
LOS ANGELES, CA / ACCESSWIRE / September 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, proclaims that it’s investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ:OFIX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading […] The post SHAREHOLDER ACTION ALERT: The Schall Law Firm Declares it’s Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm appeared first on TodaysStocks.com .
The Law Offices of Frank R. Cruz continues its investigation of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On September 12, 2023, before the market opened, Orthofix disclosed that its Board’s
(marketscreener.com) Law Offices of Howard G. Smith announces an investigation on behalf of Orthofix Medical Inc. investors concerning the Companys possible violations of federal securities laws. On September 12, 2023, before the market opened, Orthofix disclosed that its Boards independent directors made the unanimous decision to terminate for…https://www.marketscreener.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) investors concerning the Company’s possible violations of federal securities laws. On September 12, 2023, before the market opened, Orthofix disclosed that its Board’s independent directors made the unanimous decision to terminate for cause Keith Valentine, John Bostjancic and Patrick Keran from their roles as Chief Executive O
(marketscreener.com) NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. …https://www.marketscreener.
NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…